Participated · Seed · Aug 2026

Aisel Health has built a clinical operating system tailored to psychiatric workflows that converts interview recordings, documents and patient accounts into structured insights clinicians can access during consultations. The company positions its product around information retrieval rather than solely speeding note-taking, distinguishing it from generic AI scribe tools. Founded in 2024 by Augusta Klingsten Peytz and Christian Houen, Aisel is collaborating with private clinics in Denmark and has research partnerships with Region H, the University of Southern Denmark, and MedTech Growth at the Technical University of Denmark. Financially, it recently closed a €1.7M pre-seed round led by Caesar Ventures, with follow-on capital from Nordic Web Ventures, LifeX, Angel Invest and returning investors Rockstart and EIFO. Aisel plans to use the proceeds to hire clinical and engineering talent and to enter the UK market prior to raising a seed round.

Participated · Series A · Jun 2026

Ilant Health provides end-to-end, clinician-led obesity and cardiometabolic care that combines behavioral therapy, medication (GLP-1 and non-GLP-1), and surgical options within a precision-medicine model that continuously adapts treatment to individual response. The company works directly with employers and health plans to deliver measurable clinical and financial outcomes and to manage both treatment costs and total cost of care. Early results reported by Ilant show members achieve an average 15% weight loss and an average of two additional mentally healthy days per month. Ilant emphasizes data- and analytics-driven care pathways, clinician oversight, and transparent contracting for medications; it has announced direct contracting and transparent pricing through Lilly’s Employer Connect program and is working with Novo Nordisk. The company presents itself as an AI-enabled healthcare services provider that aims to move obesity care from disconnected interventions to a continuous, outcomes-focused service. Ilant has raised over $22 million to date following the $15 million Series A and is partnering with employers and payers to scale its model.

Participated · Seed · Mar 2026

HEARTio’s core product, ECGio, applies deep-learning analysis to standard 12-lead electrocardiograms to predict the presence, severity and location of coronary artery blockages without invasive testing. Early validation work includes a study in the Canadian Journal of Cardiology and a larger JACC Advances study involving more than 16,000 patients that supported the model’s ability to identify coronary artery disease from routine ECGs. The company emphasizes a headless API that uses pre-deployed ECG hardware and integrates software agents to surface subtle abnormalities for clinicians. Leadership includes co-founders Utkars Jain, Adam Butchy and Michael Leasure, with John Marous as Executive Chairman and two co-Chief Commercialisation Officers. HEARTio has public goals to complete a pivotal study, obtain FDA clearance, begin generating revenue, and expand its product suite to additional cardiac indications. The founding story is partly rooted in personal loss, and the team has received recognition including Forbes 30 Under 30.

Participated · Seed · Jan 2026

MITO AI offers a browser-based, multiplayer environment that combines foundational AI video, image, and audio models with professional-grade editing tools on an infinite canvas. Users can handle the entire creative workflow—from moodboarding and storyboarding to scripting, camera angles, visual effects, and multi-format deliverables—while directing an AI copilot that executes specific actions. The product is designed to automate tedious production tasks so storytellers can concentrate on originality and vision. Beyond the core platform, MITO is developing an AI-powered audiovisual studio that already collaborates with leading TV and movie production companies, and it plans to launch a curated marketplace of generative creators. With headquarters split between Madrid and San Francisco, the company’s mission is to democratize high-end storytelling tools and give global visibility to a new generation of creatives. MITO AI was launched in 2026 and is led by cofounder and CPO Danny Saltaren, a National Design Award recipient and former Head of Product Design at two unicorns. To date, the company has secured $4.5 million in pre-seed funding to fuel product development and ecosystem growth.

Participated · Seed · Dec 2025

InfiniteWatch offers two core products—Session Replay Agent and Voice Agent—that automatically analyze web sessions and voice calls to surface UX issues, predict failures, and recommend fixes, while also allowing companies to deploy production AI agents. The platform currently processes more than 2 million customer interactions each month for clients in financial services, e-commerce, and healthcare. Built by the former CoverWallet leadership team, the company combines monitoring, quality assurance, and agent deployment in a single system aimed at reducing revenue leakage and improving customer satisfaction. Its unified AI engine learns continuously from thousands of daily interactions to forecast problems before they impact users. Looking ahead to 2026, InfiniteWatch plans to add Messaging Agent, Email Agent, and AI Co-Browsing capabilities that will share intelligence across the platform. Founded in October 2025 with bases in New York and Madrid, the startup emerged from stealth with a $4 million pre-seed round to fund product expansion and go-to-market efforts.